Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Internal Medicine Journal|June 20, 2006
Newer options in the management of acromegalyM G Burt, K K Y HoAnnales D'Endocrinologie|May 30, 2003
Metabolic effects of oestrogens: impact of the route of administrationK K Y Ho, A J O'Sullivan, T Wolthers, et al.International Journal of Obesity (2005)|May 30, 2012
Formoterol, a highly β2-selective agonist, increases energy expenditure and fat utilisation in menP Lee, R O Day, J R Greenfield, et al.International Journal of Obesity (2005)|February 10, 2011
Metabolic sequelae of β-blocker therapy: weighing in on the obesity epidemic?P Lee, A-P Kengne, J R Greenfield, et al.Clinical Endocrinology|September 27, 2012
Associations of insulin-like growth factor-I and its binding proteins and testosterone with frailty in older menB B Yeap, S A Paul Chubb, Derrick Lopez, et al.Pituitary|November 11, 2010
Current management practices for acromegaly: an international surveyA Giustina, M D Bronstein, F F Casanueva, et al.Proceedings of the National Academy of Sciences of the United States of America|January 29, 2003
Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2K C Leung, N Doyle, M Ballesteros, et al.Psychological Medicine|September 19, 2017
High-functioning autism patients share similar but more severe impairments in verbal theory of mind than schizophrenia patientsL N W Tin, S S Y Lui, K K Y Ho, et al.Pituitary|May 7, 2025
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research societyM C Arlien-Søborg, S Radovick, M C S Boguszewski, et al.Pageof 1